Growth Metrics

Jazz Pharmaceuticals (JAZZ) Profit After Tax Growth (1y) (2011 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) PAT Growth (1y) (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - 65.80%
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn 17.05%
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - -290.15%
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn 59.59%
7 Evaxion A 62.56 Bn 62.54 Bn - -129.68%
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn -10.08%
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 1,228.66%
10 Jazz Pharmaceuticals 14.35 Bn 12.51 Bn 934.80 Mn 416.86%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 416.86%
Dec 31, 2025 6.45%
Sep 30, 2025 16.91%
Jun 30, 2025 -526.22%
Mar 31, 2025 -532.78%
Dec 31, 2024 102.98%
Sep 30, 2024 46.48%
Jun 30, 2024 61.40%
Mar 31, 2024 -121.06%
Dec 31, 2023 139.11%
Sep 30, 2023 847.25%
Jun 30, 2023 201.28%
Mar 31, 2023 4,114.94%
Dec 31, 2022 -580.95%
Sep 30, 2022 62.81%
Jun 30, 2022 109.54%
Mar 31, 2022 -98.65%
Dec 31, 2021 -126.50%
Sep 30, 2021 -135.64%
Jun 30, 2021 -416.47%
Mar 31, 2021 177.19%
Dec 31, 2020 80.31%
Sep 30, 2020 44.94%
Jun 30, 2020 -56.17%
Mar 31, 2020 -285.25%
Dec 31, 2019 -53.60%
Sep 30, 2019 -31.50%
Jun 30, 2019 183.68%
Mar 31, 2019 85.26%
Dec 31, 2018 -31.32%
Sep 30, 2018 135.05%
Jun 30, 2018 -12.58%
Mar 31, 2018 -46.84%
Dec 31, 2017 99.00%
Sep 30, 2017 -29.28%
Jun 30, 2017 -7.77%
Mar 31, 2017 14.11%
Dec 31, 2016 41.00%
Sep 30, 2016 2.12%
Jun 30, 2016 29.95%
Mar 31, 2016 7.23%
Dec 31, 2015 1.41%
Sep 30, 2015 241.38%
Jun 30, 2015 101.82%
Mar 31, 2015 176.31%
Dec 31, 2014 47.60%
Sep 30, 2014 -65.83%
Jun 30, 2014 3.49%
Mar 31, 2014 -313.36%
Dec 31, 2013 -72.43%
Sep 30, 2013 124.46%
Jun 30, 2013 35.59%
Mar 31, 2013 43.62%
Dec 31, 2012 435.19%
Sep 30, 2012 3.43%
Jun 30, 2012 -6.29%
Mar 31, 2012 38.52%
Dec 31, 2011 0.00%
Sep 30, 2011 0.00%
Jun 30, 2011 0.00%